CollPlant Biotechnologies
CLGN
CLGN
18 hedge funds and large institutions have $10.9M invested in CollPlant Biotechnologies in 2023 Q1 according to their latest regulatory filings, with 2 funds opening new positions, 5 increasing their positions, 4 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
more funds holding in top 10
Funds holding in top 10: →
more first-time investments, than exits
New positions opened: | Existing positions closed:
0.48% less ownership
Funds ownership: 14.32% → 13.84% (-0.48%)
17% less capital invested
Capital invested by funds: $13.1M → $10.9M (-$2.2M)
Holders
18
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$70.2K | |
| 2 | +$34.1K | |
| 3 | +$18.6K | |
| 4 |
Bank of America
Charlotte,
North Carolina
|
+$18.2K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$6.77K |
Top Sellers
| 1 | -$193K | |
| 2 | -$50.9K | |
| 3 | -$21.2K | |
| 4 |
SQA
Simon Quick Advisors
Morristown,
New Jersey
|
-$17.4K |
| 5 |
Zurich Cantonal Bank
Zurich,
Switzerland
|
-$491 |